Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-083025
Filing Date
2025-06-06
Accepted
2025-06-06 16:00:04
Documents
2
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1542
2 EX-24.1 cue-ex24_1.htm EX-24.1 9230
  Complete submission text file 0000950170-25-083025.txt   12370
Mailing Address C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300 SAN DIEGO CA 92121
Business Address
Broadfoot Jill Marie (Reporting) CIK: 0001305178 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 251030408

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)